BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 17, 2014
View Archived Issues
Nihon Medi-Physics and Endocyte sign license agreement for companion diagnostic
Read More
Moderna launches new venture to focus on development of mRNA Therapeutics in oncology
Read More
Elixir Medical confirms first commercial implant of the DESolve scaffold system
Read More
Sanofi and Fraunhofer-Gesellschaft form natural product center of excellence for infectious diseases
Read More
Mass General, Broad Institute and Amgen form collaboration to treat IBD
Read More
IntegraGen enters collaboration to validate oncology biomarker
Read More
Resverlogix reports results from analysis of combined data from SUSTAIN and ASSURE trials
Read More
Patch under development by Taisho and Tokuhon shows efficacy in phase III trials in osteoarthritis
Read More
Tafinlar receives FDA breakthrough therapy designation for NSCLC with BRAF mutation
Read More
TS-734 shows promise as PET-imaging agent for early detection and treatment of Alzheimer's disease
Read More
Nab-paclitaxel shows promise in esophageal squamous cell carcinoma trial
Read More
Identification of a risk factor inversely correlated with cardiometabolic disease
Read More
Cytonet files MAA with EMA for use of liver cell therapy to treat urea cycle disorders in children
Read More
Japan Tobacco and Torii gain approval for Riona Tablets in Japan
Read More
Suglat tablets approved for treatment of type 2 diabetes in Japan
Read More
Xyzal syrup for allergic disease gains approval in Japan
Read More
SYK inhibitors revealed in Portola patents
Read More
Status updates provided for phase III METIV-HCC and ATTENTION trials of tivantinib
Read More
Metabotropic glutamate mGlu5 receptor PAMs reported in Vanderbilt University patent
Read More
Takeda obtains approval of Adcetris for treatment of malignant lymphoma in Japan
Read More
Merck & Co. researchers report discovery of SYK inhibitors
Read More
Torii's sublingual immunotherapy drug for Japanese cedar pollinosis approved in Japan
Read More
Japanese MHLW approves Bayer's Adempas for CTEPH
Read More
FDA committee votes against approval of rivaroxaban for ACS indication
Read More